Free Trial

NeoGenomics (NEO) Competitors

NeoGenomics logo
$5.16 +0.32 (+6.61%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$5.16 0.00 (-0.10%)
As of 08/1/2025 07:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NEO vs. FA, DLO, ALIT, CLVT, YY, PAGS, DXC, ACVA, RNG, and PAYO

Should you be buying NeoGenomics stock or one of its competitors? The main competitors of NeoGenomics include First Advantage (FA), DLocal (DLO), Alight (ALIT), Clarivate (CLVT), JOYY (YY), PagSeguro Digital (PAGS), DXC Technology (DXC), ACV Auctions (ACVA), Ringcentral (RNG), and Payoneer Global (PAYO). These companies are all part of the "business services" industry.

NeoGenomics vs. Its Competitors

NeoGenomics (NASDAQ:NEO) and First Advantage (NYSE:FA) are both business services companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability, media sentiment and analyst recommendations.

First Advantage has a net margin of 0.65% compared to NeoGenomics' net margin of -15.10%. First Advantage's return on equity of 13.16% beat NeoGenomics' return on equity.

Company Net Margins Return on Equity Return on Assets
NeoGenomics-15.10% -2.72% -1.54%
First Advantage 0.65%13.16%7.33%

NeoGenomics presently has a consensus price target of $12.88, suggesting a potential upside of 149.52%. First Advantage has a consensus price target of $20.25, suggesting a potential upside of 22.95%. Given NeoGenomics' stronger consensus rating and higher probable upside, equities analysts clearly believe NeoGenomics is more favorable than First Advantage.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NeoGenomics
0 Sell rating(s)
8 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.33
First Advantage
0 Sell rating(s)
5 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.29

In the previous week, NeoGenomics had 37 more articles in the media than First Advantage. MarketBeat recorded 39 mentions for NeoGenomics and 2 mentions for First Advantage. First Advantage's average media sentiment score of 1.84 beat NeoGenomics' score of -0.06 indicating that First Advantage is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
NeoGenomics
3 Very Positive mention(s)
5 Positive mention(s)
16 Neutral mention(s)
7 Negative mention(s)
2 Very Negative mention(s)
Neutral
First Advantage
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

98.5% of NeoGenomics shares are held by institutional investors. Comparatively, 94.9% of First Advantage shares are held by institutional investors. 2.4% of NeoGenomics shares are held by insiders. Comparatively, 5.3% of First Advantage shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

First Advantage has higher revenue and earnings than NeoGenomics. First Advantage is trading at a lower price-to-earnings ratio than NeoGenomics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NeoGenomics$689.19M0.97-$78.73M-$0.81-6.37
First Advantage$1.05B2.74$37.29M-$0.91-18.10

NeoGenomics has a beta of 1.55, indicating that its stock price is 55% more volatile than the S&P 500. Comparatively, First Advantage has a beta of 1.24, indicating that its stock price is 24% more volatile than the S&P 500.

Summary

First Advantage beats NeoGenomics on 9 of the 16 factors compared between the two stocks.

Get NeoGenomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NEO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NEO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NEO vs. The Competition

MetricNeoGenomicsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$666.56M$2.99B$5.48B$9.53B
Dividend YieldN/A2.43%4.73%4.09%
P/E Ratio-6.3717.7428.8623.83
Price / Sales0.97178.71371.4466.13
Price / Cash11.0341.9535.4557.96
Price / Book0.788.508.265.54
Net Income-$78.73M-$55.06M$3.25B$259.28M
7 Day Performance-17.97%-3.99%-3.73%-4.67%
1 Month Performance-30.27%9.58%4.28%4.38%
1 Year Performance-69.95%6.70%25.85%17.90%

NeoGenomics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NEO
NeoGenomics
4.1222 of 5 stars
$5.16
+6.6%
$12.88
+149.5%
-70.5%$666.56M$689.19M-6.372,200Trending News
Analyst Forecast
FA
First Advantage
1.561 of 5 stars
$18.16
-1.3%
$20.25
+11.5%
-3.3%$3.15B$1.05B605.335,500Positive News
DLO
DLocal
2.668 of 5 stars
$10.99
+1.5%
$12.45
+13.3%
+36.4%$3.14B$745.97M22.431,095News Coverage
Analyst Forecast
ALIT
Alight
3.902 of 5 stars
$5.69
-1.2%
$9.86
+73.2%
-30.7%$3.06B$2.33B-40.649,500Upcoming Earnings
Gap Down
CLVT
Clarivate
3.172 of 5 stars
$4.28
-5.5%
$4.83
+12.9%
-44.1%$2.92B$2.56B-4.4112,000News Coverage
Earnings Report
YY
JOYY
1.4891 of 5 stars
$51.07
-1.8%
$35.00
-31.5%
+51.9%$2.75B$2.24B15.437,450News Coverage
Positive News
PAGS
PagSeguro Digital
3.9584 of 5 stars
$8.10
-0.7%
$11.36
+40.2%
-37.5%$2.67B$18.84B6.648,595News Coverage
DXC
DXC Technology
4.2212 of 5 stars
$14.24
-0.4%
$17.00
+19.4%
-35.3%$2.58B$12.87B6.75120,000Trending News
Earnings Report
Analyst Forecast
ACVA
ACV Auctions
N/A$14.45
-0.9%
N/AN/A$2.47B$637.16M-32.112,900
RNG
Ringcentral
4.9433 of 5 stars
$27.28
+2.2%
$33.08
+21.2%
-29.3%$2.45B$2.40B-62.004,260News Coverage
Positive News
Upcoming Earnings
PAYO
Payoneer Global
4.4041 of 5 stars
$6.72
-1.3%
$9.81
+46.0%
+11.9%$2.43B$977.72M22.402,407News Coverage
Positive News
Upcoming Earnings
Gap Down

Related Companies and Tools


This page (NASDAQ:NEO) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners